Integumen in talks about potentially buying data analytics and biophysics firms

Integumen in talks about potentially buying data analytics and biophysics firms

Integumen, which has developed an artificial skin for testing in labs instead of using animal skin, is looking at investing in a number of other areas to boost its business, it said last week.

Healthcare company Integumen is in talks about the potential acquisition of data analytics, software and biophysics companies.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events.
  • Videos and podcasts from some of the industry's most respected journalists such as Michael Brennan, Susan Mitchell and Ian Guider.
  • Access to The Business Post's extensive archive‚Äč.

Related Articles

More from The Business Post